Infliximab: a new treatment for rheumatoid arthritis

被引：8

作者：

Emery, P ^{[1
]}

机构：

[1] Univ Leeds, Leeds LS2 9NZ, W Yorkshire, England

[2] Leeds Teaching Hosp, Leeds LS2 9NZ, W Yorkshire, England

来源：

HOSPITAL MEDICINE | 2001年 / 62卷 / 03期

关键词：

D O I：

10.12968/hosp.2001.62.3.1534

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infliximab, a chimeric moose human monoclonal antibody is an anti-TNF treatment far rheumatoid arthritis. In the past there was a sizeable group of people who had exhausted disease-modifying antirheumatic drugs (DMARDs) and were left largely untreated. this has been revolutionized by treatments such as infliximab which have been shown to be effective for patients in whom standard DMARDs have failed.

引用

页码：150 / 152

页数：3

共 13 条

[1] Resistant rheumatoid arthritis clinics - a necessary development? [J].

Bingham, S ;

Emery, P .

RHEUMATOLOGY, 2000, 39 (01) :2-5

[2] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[3] Targeted therapies in rheumatoid arthritis: the need for action [J].

Emery, P ;

Panayi, G ;

Sturrock, R ;

Williams, B .

RHEUMATOLOGY, 1999, 38 (10) :911-912

[4]

Joosten LAB, 1999, J IMMUNOL, V163, P5049

[5]

Kobelt G, 1999, ARTHRITIS RHEUM-US, V42, P347, DOI 10.1002/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO

[6]

2-P

[7] Infliximab and methotrexate in the treatment of rheumatoid arthritis [J].

Lipsky, PE ;

van der Heijde, DMFM ;

St Clair, EW ;

Furst, DE ;

Breedveld, FC ;

Kalden, JR ;

Smolen, JS ;

Weisman, M ;

Emery, P ;

Feldmann, M ;

Harriman, GR ;

Maini, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1594-1602

[8] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[9]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

[10]

2-W

← 1 2 →